ENTO
Price
$0.63
Change
+$0.01 (+1.61%)
Updated
Dec 20 closing price
GENFF
Price
$0.06
Change
+$0.02 (+50.00%)
Updated
Dec 13 closing price
Ad is loading...

ENTO vs GENFF

Header iconENTO vs GENFF Comparison
Open Charts ENTO vs GENFFBanner chart's image
Entero Therapeutics
Price$0.63
Change+$0.01 (+1.61%)
Volume$64.94K
CapitalizationN/A
Genflow Biosciences
Price$0.06
Change+$0.02 (+50.00%)
Volume$100K
CapitalizationN/A
ENTO vs GENFF Comparison Chart
Loading...
ENTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTO vs. GENFF commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTO is a Hold and GENFF is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (ENTO: $0.63 vs. GENFF: $0.06)
Brand notoriety: ENTO and GENFF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTO: 21% vs. GENFF: 775%
Market capitalization -- ENTO: $3.01M vs. GENFF: $6.8M
ENTO [@Biotechnology] is valued at $3.01M. GENFF’s [@Biotechnology] market capitalization is $6.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTO’s FA Score shows that 1 FA rating(s) are green whileGENFF’s FA Score has 0 green FA rating(s).

  • ENTO’s FA Score: 1 green, 4 red.
  • GENFF’s FA Score: 0 green, 5 red.
According to our system of comparison, ENTO is a better buy in the long-term than GENFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTO’s TA Score shows that 5 TA indicator(s) are bullish.

  • ENTO’s TA Score: 5 bullish, 5 bearish.

Price Growth

ENTO (@Biotechnology) experienced а +7.90% price change this week, while GENFF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.22%. For the same industry, the average monthly price growth was -1.31%, and the average quarterly price growth was +0.77%.

Industries' Descriptions

@Biotechnology (-2.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GENFF($6.8M) has a higher market cap than ENTO($3.01M). GENFF YTD gains are higher at: 151.250 vs. ENTO (-85.000).
ENTOGENFFENTO / GENFF
Capitalization3.01M6.8M44%
EBITDA-18.46MN/A-
Gain YTD-85.000151.250-56%
P/E Ratio0.04N/A-
Revenue0N/A-
Total Cash367KN/A-
Total Debt160KN/A-
FUNDAMENTALS RATINGS
ENTO: Fundamental Ratings
ENTO
OUTLOOK RATING
1..100
46
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
76
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENTO
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
ENTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME29.820.82
+2.83%
GameStop Corp
AAPL254.494.70
+1.88%
Apple
SPY591.157.02
+1.20%
SPDR® S&P 500® ETF Trust
BTC.X95104.940000-2119.789000
-2.18%
Bitcoin cryptocurrency
TSLA421.06-15.11
-3.46%
Tesla

ENTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTO has been loosely correlated with IVVD. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTO jumps, then IVVD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTO
1D Price
Change %
ENTO100%
+1.88%
IVVD - ENTO
65%
Loosely correlated
+3.30%
SCPX - ENTO
39%
Loosely correlated
-11.03%
RLMD - ENTO
36%
Loosely correlated
+2.89%
CABA - ENTO
33%
Loosely correlated
+3.03%
GENFF - ENTO
25%
Poorly correlated
N/A
More

GENFF and

Correlation & Price change

A.I.dvisor tells us that GENFF and OTLK have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GENFF and OTLK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GENFF
1D Price
Change %
GENFF100%
N/A
OTLK - GENFF
25%
Poorly correlated
+3.60%
ENTO - GENFF
25%
Poorly correlated
+1.88%
CAPR - GENFF
25%
Poorly correlated
+1.32%
APLIF - GENFF
24%
Poorly correlated
+0.23%
TOVX - GENFF
24%
Poorly correlated
-0.87%
More